Oanæs, C.; Roalsø, M.T.T.; Alexeeva, M.; Søreide, K.
Patient-Derived Organoids from Pancreatic Neuroendocrine Tumors: A Systematic Review of PDO Take Rates, Molecular–Biological Characteristics, and Potential for Clinical Utility. Cancers 2025, 17, 3364.
https://doi.org/10.3390/cancers17203364
AMA Style
Oanæs C, Roalsø MTT, Alexeeva M, Søreide K.
Patient-Derived Organoids from Pancreatic Neuroendocrine Tumors: A Systematic Review of PDO Take Rates, Molecular–Biological Characteristics, and Potential for Clinical Utility. Cancers. 2025; 17(20):3364.
https://doi.org/10.3390/cancers17203364
Chicago/Turabian Style
Oanæs, Celine, Marcus T. T. Roalsø, Marina Alexeeva, and Kjetil Søreide.
2025. "Patient-Derived Organoids from Pancreatic Neuroendocrine Tumors: A Systematic Review of PDO Take Rates, Molecular–Biological Characteristics, and Potential for Clinical Utility" Cancers 17, no. 20: 3364.
https://doi.org/10.3390/cancers17203364
APA Style
Oanæs, C., Roalsø, M. T. T., Alexeeva, M., & Søreide, K.
(2025). Patient-Derived Organoids from Pancreatic Neuroendocrine Tumors: A Systematic Review of PDO Take Rates, Molecular–Biological Characteristics, and Potential for Clinical Utility. Cancers, 17(20), 3364.
https://doi.org/10.3390/cancers17203364